[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Assessment of the fast growing Indian Biotech Market

November 2011 | 30 pages | ID: A34C2C04284EN
Smart Research Insights

US$ 800.00

E-mail Delivery (PDF), CD-ROM Mail Delivery, Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Executive Summary

India is ranked among the top 12 biotech destinations worldwide and is the third largest market in the Asia-Pacific region. The biotechnology sector grew by 21.5 per cent in 2010-11, to cross the US$ 4 billion mark. The country is a favored destination in custom research outsourcing and custom manufacturing outsourcing (CMO).

Growth in the sector is likely to come from India's strong position in biosimilars, molecular diagnostics and personalized medicine. However, the industry is also facing various challenges such as regulatory delays, hurdles on the import–export front and constraints in the availability of venture capital.

Why should the report be purchased?

The report highlights key drivers of and trends emerging in the Indian biotechnology market. The corporate landscape of the sector in India is dotted with more than 300 players. A detailed study of key players such as Biocon, Serum Institute of India and Reliance Life Sciences has been presented.

Indian biotech industry’s potential for growth, despite its low share in the global market, has been examined. Factors driving the growth including cost-effectiveness and infrastructure facilities have been studied. The supportive role which the Indian government is playing in driving innovation in the sector, also finds mention in the report. The government has been proactively involved in formulating regulations, providing grants for fledging companies, and declaring tax incentives.

Research methodology and delivery time

Smart Research Insights has conducted in depth secondary research to arrive at key insights. Data collected from key industry sources has been analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.

The report is available as single-site single-user license. The delivery time for the electronic version of the report is 3 business days as each copy undergoes thorough quality check and is updated with the most recent information available. The delivery time for hard copies is approximately 3-5 business days, as each hard copy is custom printed for the client.

About Smart Research Insights (SRI)

SRI is a research organization which specializes in niche sector reports. We have a team of dedicated researchers with rich experience across industry segments that focus on delivering high quality analysis. We are also engaged in providing customized research solutions and company reports.
1. OVERVIEW OF THE GLOBAL BIOTECHNOLOGY INDUSTRY

2. INTRODUCTION: INDIAN BIOTECHNOLOGY INDUSTRY

2.1 Market Assessment
2.2 Outlook
2.3 Key investments

3. MARKET SEGMENTS

3.1 Agri-biotech
3.2 Bio-industrial
3.3 Bio-informatics
3.4 Bio-pharma
3.5 Bio-services

4. GROWTH DRIVERS AND EMERGING TRENDS

5. COMPETITIVE LANDSCAPE

5.1 Biocon Limited
5.2 Dr. Reddy's Laboratories
5.3 Novo Nordisk
5.4 Serum Institute of India
5.5 Panacea Biotec
5.6 Nuziveedu Seeds Limited
5.7 Reliance Life Sciences

6. GOVERNMENT INITIATIVES

7. INDUSTRY SWOT

8. RESEARCH METHODOLOGY

9. ABOUT SMART RESEARCH INSIGHTS


More Publications